Editorial: Cancer cell-intrinsic and -extrinsic factors affecting tumor immune evasion

Jiazheng Sun; Andrey A Zamyatnin Jr; Xiangliang Yuan; Yi Xiao; Hongzhong Li

doi:10.3389/fimmu.2023.1261820

Editorial: Cancer cell-intrinsic and -extrinsic factors affecting tumor immune evasion

Front Immunol. 2023 Jul 31:14:1261820. doi: 10.3389/fimmu.2023.1261820. eCollection 2023.

Authors

Jiazheng Sun¹, Andrey A Zamyatnin Jr^{2

3

4

5}, Xiangliang Yuan⁶, Yi Xiao⁶, Hongzhong Li¹

Affiliations

¹ Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
² Scientific Center for Genetics and Life Sciences, Division of Biotechnology, Sirius University of Science and Technology, Sochi, Russia.
³ Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russia.
⁴ Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
⁵ Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.
⁶ Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

No abstract available

Keywords: immune checkpoint; immune evasion; suppressive immune cell; tumor heterogeneity; tumor microenvironment.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Neoplasms*
Tumor Escape*

Grants and funding

This work was supported by the National Natural Science Foundation of China (No. 82173166, and 81472475), Natural Science Foundation of Chongqing (cstc2021jcyj-msxmX0015), Chongqing Graduate Tutor Team Construction Project, Chongqing Education Commission Foundation (cqmudstd202216), and CQMU Program for Youth Innovation in Future Medicine (NO. W0094).